Trending: GSK Signs $3 Billion Shingles Vaccine Deal in China
09 Outubro 2023 - 7:38AM
Dow Jones News
1008 GMT - GSK has been among the most mentioned companies
across news items over the past four hours, according to Factiva
data. Shares of the British pharmaceutical giant rose 0.9% after it
said it agreed on a deal valued at 2.5 billion pounds ($3.06
billion) with Chongqing Zhifei Biological Products for the
exclusive distribution of its shingles vaccine in China. The
three-year deal will start from Jan. 1 and has the option to be
further extended. Dow Jones & Co. owns Factiva.
(michael.susin@wsj.com)
(END) Dow Jones Newswires
October 09, 2023 06:23 ET (10:23 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024